These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25363110)

  • 41. The effect of methadone on depression among addicts: a systematic review and meta-analysis.
    Mohammadi M; Kazeminia M; Abdoli N; Khaledipaveh B; Shohaimi S; Salari N; Hosseinian-Far M
    Health Qual Life Outcomes; 2020 Nov; 18(1):373. PubMed ID: 33225933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Replacement therapy as a method to promote social and professional re-adaptation].
    Rotter I; Król-Pakulska E; Radlińska I; Mroczek B; Grochans E; Pakulski C; Karakiewicz B
    Gesundheitswesen; 2013 Aug; 75(8-9):500-2. PubMed ID: 23299575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation between opiate addicts in relation to judicial problems.
    Vasić G; Mihajlović G; Jovanović-Mihajlović N; Rafajlović M; Barisić J; Djukić-Dejanović S; Janković S; Radonjić K
    Srp Arh Celok Lek; 2011 Dec; 139 Suppl 1():52-6. PubMed ID: 22352204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Older adults prescribed methadone: a review of the literature across the life span from opiate initiation to methadone maintenance treatment.
    Doukas N
    Curr Drug Abuse Rev; 2014; 7(3):165-73. PubMed ID: 25563440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Commentary on Freelemyer et al. (2014): medication-assisted treatment in Africa-need is growing but response remains tepid.
    Obot IS
    Addiction; 2014 Jan; 109(1):33-4. PubMed ID: 24438111
    [No Abstract]   [Full Text] [Related]  

  • 46. Quality of life and its determinants for heroin addicts receiving a methadone maintenance program: Comparison with matched referents from the general population.
    Lin CY; Chang KC; Wang JD; Lee LJ
    J Formos Med Assoc; 2016 Sep; 115(9):714-27. PubMed ID: 26422442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings.
    Rance J; Treloar C;
    Addiction; 2014 Mar; 109(3):452-9. PubMed ID: 24678545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic Treatment with Opiate Agonists in Bulgaria - Assessing the Quality of Life Using SF 36 v. 2.
    Petrov SV; Orbetzova MM; Iliev YT; Boyadzhiev DT
    Folia Med (Plovdiv); 2016; 58(2):115-21. PubMed ID: 27552788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Categorising methadone: Addiction and analgesia.
    Keane H
    Int J Drug Policy; 2013 Nov; 24(6):e18-24. PubMed ID: 23768774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Auditory event-related potentials in methadone substituted opiate users.
    Wang GY; Kydd R; Russell BR
    J Psychopharmacol; 2015 Sep; 29(9):983-95. PubMed ID: 26038111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concurrent drug use among methadone maintenance patients in mountainous areas in northern Vietnam.
    Tran BX; Boggiano VL; Thi Nguyen HL; Nguyen LH; Nguyen HV; Hoang CD; Le HT; Tran TD; Le HQ; Latkin CA; Thi Vu TM; Zhang MW; Ho RC
    BMJ Open; 2018 Mar; 8(3):e015875. PubMed ID: 29567839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New community-based methadone maintenance treatment programs in Guangdong, China, and their impact on patient quality of life.
    He Q; Wang X; Xia Y; Mandel JS; Chen A; Zhao L; Han L; Ling L
    Subst Use Misuse; 2011; 46(6):749-57. PubMed ID: 21114401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
    Hser YI; Saxon AJ; Huang D; Hasson A; Thomas C; Hillhouse M; Jacobs P; Teruya C; McLaughlin P; Wiest K; Cohen A; Ling W
    Addiction; 2014 Jan; 109(1):79-87. PubMed ID: 23961726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychological distress mediated the effects of self-stigma on quality of life in opioid-dependent individuals: A cross-sectional study.
    Chang KC; Lin CY; Chang CC; Ting SY; Cheng CM; Wang JD
    PLoS One; 2019; 14(2):e0211033. PubMed ID: 30726249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monthly take-home methadone maintenance regime for elderly opium-dependent users in Singapore.
    Guo S; Winslow M; Manning V; Thane KK
    Ann Acad Med Singap; 2010 Jun; 39(6):429-34. PubMed ID: 20625617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reliability and validity of the Treatment Outcome Profile among patients attending methadone maintenance treatment programs in Kunming, China.
    Wang M; Shen J; Liu X; Deng Y; Li J; Finch E; Wolff K
    J Subst Abuse Treat; 2017 Jun; 77():89-94. PubMed ID: 28476278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.